Markets Daily

Head-To-Head Survey: Moody’s (MCO) vs. Its Competitors

Posted by Tristan Rich on Nov 6th, 2026

Moody’s (NYSE:MCO – Get Free Report) is one of 1,744 publicly-traded companies in the “Capital Markets” industry, but how does it weigh in compared to its rivals? We will compare Moody’s to related businesses... More »

Contrasting Haemonetics (NYSE:HAE) & UFP Technologies (NASDAQ:UFPT)

Posted by Michael Walen on Nov 6th, 2026

Haemonetics (NYSE:HAE – Get Free Report) and UFP Technologies (NASDAQ:UFPT – Get Free Report) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength... More »

Head to Head Survey: Trane Technologies (NYSE:TT) vs. Builders FirstSource (NYSE:BLDR)

Posted by Tristan Rich on Nov 6th, 2026

Builders FirstSource (NYSE:BLDR – Get Free Report) and Trane Technologies (NYSE:TT – Get Free Report) are both industrials companies, but which is the superior stock? We will compare the two businesses based on the strength... More »

Personalis (NASDAQ:PSNL) Announces Quarterly Earnings Results

Posted by Danessa Lincoln on Nov 6th, 2026

Personalis (NASDAQ:PSNL – Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.06), FiscalAI reports. The firm... More »

Hut 8 (NASDAQ:HUT) Posts Quarterly Earnings Results, Beats Estimates By $1.70 EPS

Posted by Danessa Lincoln on Nov 6th, 2026

Hut 8 (NASDAQ:HUT – Get Free Report) posted its earnings results on Wednesday. The company reported $0.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.72) by $1.70, FiscalAI reports.... More »

Janux Therapeutics (NASDAQ:JANX) Stock Price Expected to Rise, Barclays Analyst Says

Posted by Michael Walen on Nov 6th, 2026

Janux Therapeutics (NASDAQ:JANX – Get Free Report) had its target price raised by equities research analysts at Barclays from $14.00 to $15.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently... More »

Affirm (NASDAQ:AFRM) Given New $100.00 Price Target at Barclays

Posted by Kim Johansen on Nov 6th, 2026

Affirm (NASDAQ:AFRM – Get Free Report) had its target price dropped by analysts at Barclays from $105.00 to $100.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently has an “overweight”... More »

Microchip Technology Incorporated (NASDAQ:MCHP) Declares Quarterly Dividend of $0.46

Posted by Michael Walen on Nov 6th, 2026

Microchip Technology Incorporated (NASDAQ:MCHP – Get Free Report) announced a quarterly dividend on Thursday, November 5th. Shareholders of record on Monday, November 23rd will be paid a dividend of $0.4550 per share by the semiconductor... More »

Neuronetics (NASDAQ:STIM) Stock Price Target Raised at B. Riley Financial

Posted by Kim Johansen on Nov 6th, 2026

Neuronetics (NASDAQ:STIM – Get Free Report) had its target price lifted by investment analysts at B. Riley Financial from $5.00 to $6.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage presently... More »

Consolidated Edison (NYSE:ED) Price Target Raised to $108.00

Posted by Michael Walen on Nov 6th, 2026

Consolidated Edison (NYSE:ED – Get Free Report) had its price target upped by equities researchers at Barclays from $106.00 to $108.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has an “underweight”... More »

TripAdvisor (NASDAQ:TRIP) Stock Gets Price Target Trim from B. Riley Financial

Posted by Kim Johansen on Nov 6th, 2026

TripAdvisor (NASDAQ:TRIP – Get Free Report) had its price target lowered by investment analysts at B. Riley Financial from $12.50 to $8.50 in a research report issued on Friday, Benzinga reports. The firm presently has a “neutral”... More »

MGIC Investment (NYSE:MTG) Stock Price Expected to Rise, Barclays Analyst Says

Posted by Danessa Lincoln on Nov 6th, 2026

MGIC Investment (NYSE:MTG – Get Free Report) had its price target upped by equities research analysts at Barclays from $29.00 to $30.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has an “equal... More »

Barclays Forecasts Strong Price Appreciation for Insulet (NASDAQ:PODD) Stock

Posted by Danessa Lincoln on Nov 6th, 2026

Insulet (NASDAQ:PODD – Get Free Report) had its price target raised by investment analysts at Barclays from $150.00 to $165.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “equal weight”... More »

Nova (NASDAQ:NVMI) Shares Climb 10.9% Following Better-Than-Expected Earnings

Posted by Sarita Garza on Nov 6th, 2026

Nova Ltd. (NASDAQ:NVMI – Get Free Report) shares rose 10.9% during trading on Friday following a stronger than expected earnings report. The stock traded as high as $314.07 and last traded at $310.9580. Approximately 161,966... More »

Analyzing RH (NYSE:RH) and Asbury Automotive Group (NYSE:ABG)

Posted by Kim Johansen on Nov 6th, 2026

Asbury Automotive Group (NYSE:ABG – Get Free Report) and RH (NYSE:RH – Get Free Report) are both mid-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the... More »

The Latest Headlines at Markets Daily